Leanne B. Gasink

Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study

Yehuda Carmeli, J. Armstrong, Peter J. Laud et al. · The Lancet Infectious Diseases · 2016 · 399 citations

Urinary Tract Infections, Urology, Antimicrobial Susceptibility +11

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

John E. Mazuski, Leanne B. Gasink, J. Armstrong et al. · Clinical Infectious Diseases · 2016 · 376 citations · Full text

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Florian Wagenlehner, Jack D. Sobel, Paul Newell et al. · Clinical Infectious Diseases · 2016 · 338 citations · Full text

Risk Factors and Clinical Impact of <i>Klebsiella pneumoniae</i> Carbapenemase-Producing <i>K. pneumoniae</i>

Leanne B. Gasink, Paul H. Edelstein, Ebbing Lautenbach et al. · Infection Control and Hospital Epidemiology · 2009 · 308 citations · Full text

Clinical and Microbiological Outcomes of Serious Infections with Multidrug-Resistant Gram-Negative Organisms Treated with Tigecycline

Kara B. Anthony, Neil O. Fishman, Darren R. Linkin et al. · Clinical Infectious Diseases · 2008 · 212 citations · Full text

Klebsiella Pneumoniae, Antimicrobial Chemotherapy, Antibiotic Resistance +17